Mutation detection of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha for treatment guidance in breast cancer
Breast cancer remains a significant health concern worldwide, with diverse molecular subtypes that necessitate personalized therapeutic approaches. Recent advances have highlighted the importance of molecular signatures in guiding breast cancer treatment. Among these, the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutation has emerged as a crucial factor in determining the efficacy of targeted therapies, particularly in advanced breast cancer. This review explores the role of PIK3CA mutation detection in breast cancer and its implications for personalized treatment strategies.
Breast Cancer Heterogeneity
Breast ...










